<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Imanishi T</submitter><funding>NCI NIH HHS</funding><funding>Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science KAKENHI</funding><pagination>e201800282</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6348487</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(1)</volume><pubmed_abstract>Stimulator of interferon genes (STING) plays a key role in detecting cytosolic DNA and induces type I interferon (IFN-I) responses for host defense against pathogens. Although T cells highly express STING, its physiological role remains unknown. Here, we show that costimulation of T cells with the STING ligand cGAMP and TCR leads to IFN-I production and strongly inhibits T-cell growth. TCR-mediated mTORC1 activation and sustained activation of IRF3 are required for cGAMP-induced IFN-I production, and the mTORC1 activity is partially counteracted by cGAMP, thereby blocking proliferation. This mTORC1 inhibition in response to costimulation depends on IRF3 and IRF7. Effector T cells produce much higher IFN-I levels than innate cells in response to cGAMP. Finally, we demonstrated that STING stimulation in T cells is effective in inducing antitumor responses in vivo. Our studies demonstrate that the outputs of STING and TCR signaling pathways are mutually regulated through mTORC1 to modulate T-cell functions.</pubmed_abstract><journal>Life science alliance</journal><pubmed_title>Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function.</pubmed_title><pmcid>PMC6348487</pmcid><funding_grant_id>16K08852</funding_grant_id><funding_grant_id>R01 CA194404</funding_grant_id><pubmed_authors>Hoshii T</pubmed_authors><pubmed_authors>Hirao A</pubmed_authors><pubmed_authors>Saito T</pubmed_authors><pubmed_authors>Matsuda S</pubmed_authors><pubmed_authors>Miyake K</pubmed_authors><pubmed_authors>Arita M</pubmed_authors><pubmed_authors>Akira S</pubmed_authors><pubmed_authors>Unno M</pubmed_authors><pubmed_authors>Ikeda K</pubmed_authors><pubmed_authors>Barber GN</pubmed_authors><pubmed_authors>Ishii KJ</pubmed_authors><pubmed_authors>Imanishi T</pubmed_authors><pubmed_authors>Yoneda N</pubmed_authors><pubmed_authors>Kobayashi W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function.</name><description>Stimulator of interferon genes (STING) plays a key role in detecting cytosolic DNA and induces type I interferon (IFN-I) responses for host defense against pathogens. Although T cells highly express STING, its physiological role remains unknown. Here, we show that costimulation of T cells with the STING ligand cGAMP and TCR leads to IFN-I production and strongly inhibits T-cell growth. TCR-mediated mTORC1 activation and sustained activation of IRF3 are required for cGAMP-induced IFN-I production, and the mTORC1 activity is partially counteracted by cGAMP, thereby blocking proliferation. This mTORC1 inhibition in response to costimulation depends on IRF3 and IRF7. Effector T cells produce much higher IFN-I levels than innate cells in response to cGAMP. Finally, we demonstrated that STING stimulation in T cells is effective in inducing antitumor responses in vivo. Our studies demonstrate that the outputs of STING and TCR signaling pathways are mutually regulated through mTORC1 to modulate T-cell functions.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Feb</publication><modification>2026-05-01T01:14:39.646Z</modification><creation>2025-05-29T14:37:32.995Z</creation></dates><accession>S-EPMC6348487</accession><cross_references><pubmed>30683688</pubmed><doi>10.26508/lsa.201800282</doi></cross_references></HashMap>